Mitoquinone Mesylate and Mitochondrial DNA in End Organs in Humanized Mouse Model of Chronic Treated Human Immunodeficiency Virus Infection
The Journal of Infectious Diseases · 28.06.2023 · 228 (1) · 59-63
DOI: 10.1093/infdis/jiad044 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 24.03.2023. Verfasst von Sihyeong Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, Californ…. Hauptthemen laut MEDLINE: DNA, Mitochondrial, HIV Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
No treatment exists for mitochondrial dysfunction, a contributor to end-organ disease in human immunodeficiency virus (HIV). The mitochondrial antioxidant mitoquinone mesylate (MitoQ) attenuates mitochondrial dysfunction in preclinical mouse models of various diseases but has not been used in HIV. We used a humanized murine model of chronic HIV infection and polymerase chain reaction to show that HIV-1–infected mice treated with antiretroviral therapy and MitoQ for 90 days had higher ratios of human and murine mitochondrial to nuclear DNA in end organs compared with HIV-1–infected mice on antiretroviral therapy. We offer translational evidence of MitoQ as treatment for mitochondrial dysfunction in HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Theodoros Kelesidis
Förderung
- NIA NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- California HIV/AIDS Research Program
- Campbell Foundation
Zitieren
APA
Song, S., Satta, S., Sharma, M. B., Hugo, C., Kossyvakis, A., Sen Roy, S., & Kelesidis, T. (2023). Mitoquinone Mesylate and Mitochondrial DNA in End Organs in Humanized Mouse Model of Chronic Treated Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases, 228(1), 59-63. https://doi.org/10.1093/infdis/jiad044
Vancouver
Song S, Satta S, Sharma MB, Hugo C, Kossyvakis A, Sen Roy S, et al. Mitoquinone Mesylate and Mitochondrial DNA in End Organs in Humanized Mouse Model of Chronic Treated Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 2023;228(1):59-63. doi:10.1093/infdis/jiad044
BibTeX
@article{Song2023,
author = {Song, Sihyeong and Satta, Sandro and Sharma, Madhav B and Hugo, Cristelle and Kossyvakis, Athanassios and Sen Roy, Shubhendu and Kelesidis, Theodoros},
title = {Mitoquinone Mesylate and Mitochondrial DNA in End Organs in Humanized Mouse Model of Chronic Treated Human Immunodeficiency Virus Infection},
journal = {The Journal of Infectious Diseases},
year = {2023},
volume = {228},
number = {1},
pages = {59--63},
doi = {10.1093/infdis/jiad044}
}
EUVIMED